This is the video recording of the January 17, 2024, Hot Corner Insider Weekly Strategy Session.
CEO Frost Buys 1,000,000 OPK Shares
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes via a handful of filings by the CEO and chairman of OPKO Health $OPK, Phillip Frost.
Frost reported a total purchase of 1,000,000 OPK shares, equivalent to $954,300.
The Minor Leaguers (01-16-2024)
From the Desk of Steve Strazza @Sstrazza
Welcome to The Minor Leaguers.
We’ve had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.
For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.
That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.
We expanded our universe to include some mid-caps.
To make the cut for our Minor Leaguers list now, a company must have a market cap between $1 and $4B.
And it doesn’t have to be a Russell component — it can be any US-listed equity. With participation expanding around the globe, we want all those ADRs in our universe.
The same price and liquidity filters are applied. Then, as always, we sort by proximity to new highs in order to focus on the best players.
The goal is to catch the strongest names while they’re small and have serious upside potential. If any of these stocks ever climb the ranks to the big leagues, the returns could be huge.
We’re looking at up to 10x moves just to break into large-cap land!
Let’s dive into this week’s report and see what’s happening in some of the hottest stocks in the Minor Leagues.
Insiders Are Buying TLRY Shares
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in the form of filings by the CEO, the CFO, and the global general counsel of Tilray Brands Inc $TLRY.
Each filed Form 4s revealing combined purchases of TLRY shares in the total amount of $148,454.
The Hall of Famers (01-12-2024)
From the desk of Steve Strazza @Sstrazza
Our Hall of Famers list is composed of the 150 largest US-based stocks.
These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.
It has all the big names and more.
It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that. Click here to check it out.
The Hall of Famers is simple.
We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.
Let’s dive right in and check out what these big boys are up to.
Forbion Capital GP Kersten Reports a $26 Million DYN Buy
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Dirk Kersten.
Kersten, who is general partner at Forbion Capital Fund, reported a purchase of roughly $26 million in Dyne Therapeutics Inc $DYN.
Junior Hall of Famers (01-11-2024)
From the Desk of Steve Strazza @Sstrazza
We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to offer.
However, when it comes to our latest project, it couldn’t be any simpler!
With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US stocks.
Welcome to The Junior Hall of Famers.
This scan is composed of the next 150 largest stocks by market cap, those that come after the top 150 and are thus covered by the Hall of Famers universe. Many of these names will someday graduate and join our original Hall Of Famers list. The idea here is to catch these big trends as early on as possible.
There is no need to overcomplicate things. Market cap is a quality filter at the end of the day. It only grows if price is rising. That’s good enough for us.
The bottom line is it is a bull market. We want as many vehicles and options to express our bullish thesis as possible. This is a good way to do just that.
Let’s dive right in and check out what these future big boys are up to.
Baker Bros Boosts Its KYMR, REPL Stakes
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a 13G filing by Baker Bros Advisors LP.
The hedge fund increased its ownership position in Kymera Therapeutics Inc $KYMR from 9.2% to 10.8%.
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 267
- Next Page »